NCT01226394 2026-04-06
ProphyloCHIP
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Completed
Clinical Trials
12 trialsNCT06839092 2025-07-30
PROPAC
University Hospital, Geneva
Phase 3 Not yet recruiting
NCT03348150 2025-07-17
PERISCOPEII
The Netherlands Cancer Institute
Phase 3 Active not recruiting
NCT01462890 2022-07-20
BOOST
AGO Study Group
Phase 3 Completed
NCT02231086 2021-09-16
COLOPEC
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 3 Completed
NCT02158988 2021-07-29
GASTRIPEC
Charite University, Berlin, Germany
Phase 3 Completed
NCT04370925 2020-06-16
Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 3 Recruiting
NCT02681432 2018-08-21
hipecova
Hospital General de Ciudad Real
Phase 3 Unknown
NCT02840331 2017-10-27
Hypericin-PDT
University Hospital Tuebingen
Phase 3 Unknown
NCT03221608 2017-07-18
Clinical Analysis of HIPEC for T4 Colorectal Cancer After Surgery
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3 Unknown
NCT03179579 2017-06-07
Efficacy of HIPEC Combined With Systemic Chemotherapy and CRS on Peritoneal Metastases From Gastric Cancer
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 3 Unknown
NCT00769405 2016-08-30
Systemic Chemotherapy With or Without Intraperitoneal Chemohyperthermia in Treating Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer
UNICANCER
Phase 3 Completed